The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 3, 2014, Pages 370-376

  Ousdigian, Kevin T ^a   Borek, P Peter ^b   Koehler, Jodi L ^a   Heywood, J Thomas ^c   Ziegler, Paul D ^a   Wilkoff, Bruce L ^d  

^a MEDTRONIC INC   (United States)

^b Centennial Heart Cardiovascular Consultants   (United States)

^c SCRIPPS CLINIC   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fbrillation; Cardiac resynchronization therapy; Heart failure; Heart rate; Mortality

Indexed keywords

ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; HEART RATE; MORTALITY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 84905822888     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.001212     Document Type: Article

References (21)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defbrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defbrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
2. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616.
3. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol. 2009;53:355-360.
4. Maisel WH, Stevenson LW. Atrial fbrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6A):2D-8D.
5. Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm. 2006;3:1445-1452.
6. Hayes DL, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Seth M, Jones PW, Saxon LA. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8:1469-1475.
7. Swerdlow CD, Schsls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD. Detection of atrial fbrillation and futter by a dual-chamber implantable cardioverter-defbrillator. For the Worldwide Jewel AF Investigators. Circulation. 2000;101:878-885.
8. Fuster V, Rydén LE, Cannom DS, Crijns H, Curtis A, Ellenbogen K, Halperin J, LeHeuzey J, Kay N, Lowe J, Olsson S, Prystowsky E, Tamargo J, Wann S. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fbrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation. 2006;114:700-752.
9. Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resyn-chronization therapy pacing: insights from 32 844 patients. Circ Arrhythm Electrophysiol. 2012;5:884-888.
10. Santini M, Gasparini M, Landolina M. Device-detected atrial tachyar-rhythmias predict adverse outcome in real-world patients with implantable biventricular defbrillators. J Am Coll Cardiol. 2011;57:167-172.
11. Wilton SB, Leung AA, Ghali WA, Faris P, Exner DV. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fbrillation: a systematic review and meta-analysis. Heart Rhythm. 2011;8:1088-1094.
12. Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JG, Freemantle N, Erdmann E. Effect of cardiac resynchronization on the incidence of atrial fbrillation in patients with severe heart failure. Circulation. 2006;114:18-25.
13. Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS; RAFT Investigators. Cardiac resynchronization therapy in patients with permanent atrial fbril-lation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail. 2012;5:566-570.
14. Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP. Cardiac resynchronization in patients with atrial fbrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008;52: 1239-1246.
15. Kamath GS, Cotiga D, Koneru JN, Arshad A, Pierce W, Aziz EF, Mandava A, Mittal S, Steinberg JS. The utility of 12-lead Holter monitoring in patients with permanent atrial fbrillation for the identifcation of non-responders after cardiac resynchronization therapy. J Am Coll Cardiol. 2009;53:1050-1055.
16. Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF, Breithard O, Brignole M, Cleland J, DeLurgio DB, Dickstein K, Exner DV, Gold M, Grimm RA, Hayes DL, Israel C, Leclercq C, Linde C, Lindenfeld J, Merkely B, Mont L, Murgatroyd F, Prinzen F, Saba SF, Shinbane JS, Singh J, Tang AS, Vardas PE, Wilkoff BL, Zamorano JL. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm. 2012;9:1524-1576.
17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-1847.
18. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P, Pini D, Ceriotti C, Gronda E, Klersy C, Fratini S, Klein HH. Four-year effcacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fbrillation. J Am Coll Cardiol. 2006;48:734-743.
19. Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fbrillation and heart failure a systematic review. J Am Coll Cardiol. 2012;59:719-726.
20. Gasparini M, Leclercq C, Lunati M, Landolina M, Auricchio A, Santini M, Boriani G, Proclemer A, Curnis A, Leyva F. Cardiac resynchronization therapy in patients with atrial fbrillation: the CERTIFY study. Europace. 2013;15:ii46-ii47. Abstract.
21. Gasparini M, Boriani G. Letter by Gasparini and Boriani regarding article, "Cardiac resynchronization therapy in patients with permanent atrial fbrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)." Circ Heart Fail. 2013;6:e22.